Condition: X-Linked Hypophosphatemia · Sponsor: Kyowa Kirin Pharmaceutical Development Ltd
This is an international, multicentre, prospective, non-interventional, observational Registry of patients with X-Linked hypophosphatemia (XLH). The main objective of this XLH Registry is to collect data to characterise the treatment, progression and long-term outcomes of XLH in both adult and paediatric settings.
This description comes directly from the study's public registry record.
Clinical Trial Cordinator · +49 15114861167 · KKI-IMA-XLH-Registry@kyowakirin.com
Always discuss trial participation with your own doctor first.
| Hopital Universitaire des Enfants Reine Fabiola | Brussels, Belgium | Active Not Recruiting |
| Universitair Ziekenhuis Brussel | Brussels, Belgium | Active Not Recruiting |
| Cliniques Universitaires Saint-Luc | Brussels, Belgium | Active Not Recruiting |
| UZA | Edegem, Belgium | Active Not Recruiting |
| Universitair Ziekenhuis Gent | Ghent, Belgium | Active Not Recruiting |
| UZ Leuven | Leuven, Belgium | Active Not Recruiting |
| CHU de Liège | Liège, Belgium | Active Not Recruiting |
| SHATPD "Prof Ivan Mitev" EAD | Sofia, Bulgaria | Active Not Recruiting |
| UMHAT "SofiaMed", OOD | Sofia, Bulgaria | Active Not Recruiting |
| Children Hospital | Brno, Czechia | Active Not Recruiting |
| Fakultni nemocnice v Motole | Prague, Czechia | Active Not Recruiting |
| Aalborg University Hospital | Aalborg, Denmark | Active Not Recruiting |
+ 106 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03193476